T-cell receptor (TcR)-CD3 complex

Industry

CPC
C07K14/7051

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K14/00Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof

Current Industry

C07K14/7051T-cell receptor (TcR)-CD3 complex

Industries

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for car T cell therapy
- Patent number 12,144,850
- Issue date Nov 19, 2024
- Purdue Research Foundation
- Philip Stewart Low
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-PTK7 immune cell cancer therapy
- Patent number 12,146,157
- Issue date Nov 19, 2024
- Jonathan Alexander Terrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Human Kynureninase enzymes and uses thereof
- Patent number 12,144,828
- Issue date Nov 19, 2024
- Board of Regents, The University of Texas System
- George Georgiou
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunosuppressive antigen-specific chimeric antigen receptor Treg c...
- Patent number 12,144,829
- Issue date Nov 19, 2024
- The University of Toledo
- Juan Carlos Jaume
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating EGFRvIII expressing glioblastomas
- Patent number 12,144,826
- Issue date Nov 19, 2024
- The Regents of the University of California
- Wendell A. Lim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Regulatory T cells targeted by lymphotoxin alpha blocking agent and...
- Patent number 12,146,160
- Issue date Nov 19, 2024
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Magali Irla
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T cell modification and use thereof
- Patent number 12,145,990
- Issue date Nov 19, 2024
- ADAPTIMMUNE LIMITED
- Garth Hamilton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vaccinal strategy
- Patent number 12,144,851
- Issue date Nov 19, 2024
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- François Lang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,144,852
- Issue date Nov 19, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
EphA3 directed CAR-T cells for treatment of tumors
- Patent number 12,139,544
- Issue date Nov 12, 2024
- Mayo Foundation for Medical Education and Research
- Cameron Durrant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-LMP2 TCR-T cell therapy for the treatment of EBV-associated ca...
- Patent number 12,139,523
- Issue date Nov 12, 2024
- Duke University
- Xiao-Fan Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
T-cells comprising two different chimeric antigen receptors and use...
- Patent number 12,139,522
- Issue date Nov 12, 2024
- THE MEDICAL RESEARCH INFRASTRUCTURE AND HEAL SERVICED FUND OF THE TEL AVIV ME...
- Zelig Eshhar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...
- Patent number 12,139,538
- Issue date Nov 12, 2024
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immune cell compositions and methods of use
- Patent number 12,139,524
- Issue date Nov 12, 2024
- Memorial Sloan Kettering Cancer Center
- Prasad S. Adusumilli
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antigen-binding polypeptide targeting B7H3 and application thereof
- Patent number 12,133,890
- Issue date Nov 5, 2024
- NINGBO T-MAXIMUM BIOPHARMACEUTICALS CO., LTD.
- Xiaoyun Shang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
MART-1(27-35) epitope-specific T cell receptor
- Patent number 12,134,637
- Issue date Nov 5, 2024
- BGI SHENZHEN
- Fei Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Universal anti-CD22 chimeric antigen receptor engineered immune cells
- Patent number 12,133,867
- Issue date Nov 5, 2024
- Cellectis SA
- Julianne Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using chimeric antigen receptor and protein kin...
- Patent number 12,128,069
- Issue date Oct 29, 2024
- The Trustees of the University of Pennsylvania
- Steven M. Albelda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TCR/BCR profiling using enrichment with pools of capture probes
- Patent number 12,129,519
- Issue date Oct 29, 2024
- Tempus AI, Inc.
- Jason Perera
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-GPC3 antibody
- Patent number 12,129,291
- Issue date Oct 29, 2024
- Yamaguchi University
- Koji Tamada
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods, kits, agents and apparatuses for transduction
- Patent number 12,129,477
- Issue date Oct 29, 2024
- Juno Therapeutics GmbH
- Keenan Bashour
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Blockade of CD2 surface expression and expression of chimeric antig...
- Patent number 12,129,485
- Issue date Oct 29, 2024
- National University of Singapore
- Dario Campana
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors and uses thereof
- Patent number 12,121,539
- Issue date Oct 22, 2024
- BIOSCEPTRE (AUST) PTY LTD
- Justin Taylor Coombs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
BCMA chimeric antigen receptor based on single domain antibody and...
- Patent number 12,121,542
- Issue date Oct 22, 2024
- SHENZHEN PREGENE BIOPHARMA CO. LTD.
- Jishuai Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,121,572
- Issue date Oct 22, 2024
- Immatics Biotechnologies GmbH
- Toni Weinschenk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of redirecting t cells to treat HIV infection
- Patent number 12,122,820
- Issue date Oct 22, 2024
- The Trustees of the University of Pennsylvania
- James L. Riley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating cancer with anti-CD19/CD22 im...
- Patent number 12,122,831
- Issue date Oct 22, 2024
- LENTIGEN TECHNOLOGY, INC.
- Dina Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gene-regulating compositions and methods for improved immunotherapy
- Patent number 12,123,021
- Issue date Oct 22, 2024
- KSQ Therapeutics, Inc.
- Micah Benson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Human alpha-folate receptor chimeric antigen receptor
- Patent number 12,122,829
- Issue date Oct 22, 2024
- The Trustees of the University of Pennsylvania
- Daniel J. Powell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptor for tumor targeting
- Patent number 12,122,846
- Issue date Oct 22, 2024
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR THE TREATMENT OF ANAPLASTIC LARGE CELL LYMPHOMA
- Publication number 20240382592
- Publication date Nov 21, 2024
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Erika CAUSSE BRUNET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION
- Publication number 20240384007
- Publication date Nov 21, 2024
- Novartis AG
- James E. Bradner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACID CONSTRUCT
- Publication number 20240384278
- Publication date Nov 21, 2024
- AUTOLUS LIMITED
- Shaun Cordoba
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR ENHANCING THE SUPPRESSIVE PROPERTIES OF TREG CELLS
- Publication number 20240384301
- Publication date Nov 21, 2024
- UCL Business LTD
- Hans Stauss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-GPRC5D ANTIGEN BINDING PROTEIN AND USE THEREOF
- Publication number 20240384001
- Publication date Nov 21, 2024
- Oricell Therapeutics Co., Ltd.
- Xiaowen HE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY ENGINEERED CELLS AND USES THEREOF
- Publication number 20240383962
- Publication date Nov 21, 2024
- Zhuo Huang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATMENT
- Publication number 20240382588
- Publication date Nov 21, 2024
- MONASH UNIVERSITY
- Joshua Daniel OOI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODY LOADED IMMUNE CELLS AND METHODS FOR USE IN CANCER TREATMENT
- Publication number 20240382593
- Publication date Nov 21, 2024
- Board of Regents, The University of Texas System
- Katy REZVANI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD4+ AND/OR CD8+ CELL POPULATIONS COMPRISING ICARS FOR USE IN TREAT...
- Publication number 20240382525
- Publication date Nov 21, 2024
- Gavish-Galilee Bio Applications Ltd.
- Michael WEIST
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS OF PHOSPHOLIPASE A2 RECEPTOR CHIMERIC AUTO...
- Publication number 20240383965
- Publication date Nov 21, 2024
- The Trustees of the University of Pennsylvania
- Saar Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
- Publication number 20240383992
- Publication date Nov 21, 2024
- Oricell Therapeutics Co., Ltd.
- Siye CHEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLULAR THERAPY TO SUPPRESS IMMUNE RESPONSE
- Publication number 20240382587
- Publication date Nov 21, 2024
- THE TRUSTEES OF INDIANA UNIVERSITY
- Moanaro BISWAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITION USING PATIENT-DERIVED AUTOLOGOUS NEOANTIGEN...
- Publication number 20240382591
- Publication date Nov 21, 2024
- The University of Chicago
- Hans SCHREIBER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS ME...
- Publication number 20240376442
- Publication date Nov 14, 2024
- SOTIO BIOTECH INC.
- Kathleen McGinness
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO...
- Publication number 20240376197
- Publication date Nov 14, 2024
- The Trustees of the University of Pennsylvania
- Marco Ruella
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS
- Publication number 20240376201
- Publication date Nov 14, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TFR ANTIGEN BINDING PROTEINS AND USES THEREOF
- Publication number 20240376222
- Publication date Nov 14, 2024
- The Board of Regents of the University of Texas System
- Zhiqiang AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BAG6 SPECIFIC CHIMERIC ANTIGEN RECEPTOR, NUCLEIC ACID, BAG6 SPECIFI...
- Publication number 20240374726
- Publication date Nov 14, 2024
- China Medical University Hospital
- Der-Yang Cho
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BINDING DOMAIN
- Publication number 20240374727
- Publication date Nov 14, 2024
- UCL Business LTD
- Marc Mansour
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION OF ANTIGEN SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-ST...
- Publication number 20240374729
- Publication date Nov 14, 2024
- MEDIGENE IMMUNOTHERAPIES GMBH
- Maja BÜRDEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NR4A3-DEFICIENT IMMUNE CELLS AND USES THEREOF
- Publication number 20240374725
- Publication date Nov 14, 2024
- Lyell Immunopharma, Inc.
- Viola LAM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENERATION OF CAR MODIFIERS FOR TUMOR TREATMENT
- Publication number 20240374641
- Publication date Nov 14, 2024
- The Trustees of the University of Pennsylvania
- Donald M. O'Rourke
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
T Cell Modification
- Publication number 20240374728
- Publication date Nov 14, 2024
- ADAPTIMMUNE LIMITED
- Luca MELCHIORI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Cell Selection Methods and Related Compositions
- Publication number 20240377394
- Publication date Nov 14, 2024
- The Board of Trustees of the Leland Stanford Junior University
- Louai Labanieh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CAR-EXPRESSING IMMUNE CELLS THAT SPECIFICALLY TARGET MESOTHELIN AND...
- Publication number 20240374721
- Publication date Nov 14, 2024
- Takeda Pharmaceutical Company Limited
- Chihiro Take
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS
- Publication number 20240376429
- Publication date Nov 14, 2024
- Baylor College of Medicine
- David H. Quach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Chimeric Antigen Receptor-Modified NK-92 Cells
- Publication number 20240366972
- Publication date Nov 7, 2024
- ImmunityBio, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTISPECIFIC ANTIGEN-BINDING MOLECULES FOR CELL TARGETING AND USES...
- Publication number 20240368312
- Publication date Nov 7, 2024
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CAR T CELL THERAPY AND IFN GAMMA
- Publication number 20240366662
- Publication date Nov 7, 2024
- CITY OF HOPE
- Darya Alizadeh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUSION PROTEINS AND USES THEREOF
- Publication number 20240366761
- Publication date Nov 7, 2024
- LEGEND BIOTECH IRELAND LIMITED
- Xiaohu FAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

T-cell receptor (TcR)-CD3 complex

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Methods and compositions for car T cell therapy

Anti-PTK7 immune cell cancer therapy

Human Kynureninase enzymes and uses thereof

Immunosuppressive antigen-specific chimeric antigen receptor Treg c...

Methods of treating EGFRvIII expressing glioblastomas

Regulatory T cells targeted by lymphotoxin alpha blocking agent and...

T cell modification and use thereof

Vaccinal strategy

Peptides and combination of peptides for use in immunotherapy again...

EphA3 directed CAR-T cells for treatment of tumors

Anti-LMP2 TCR-T cell therapy for the treatment of EBV-associated ca...

T-cells comprising two different chimeric antigen receptors and use...

Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...

Immune cell compositions and methods of use

Antigen-binding polypeptide targeting B7H3 and application thereof

MART-1(27-35) epitope-specific T cell receptor

Universal anti-CD22 chimeric antigen receptor engineered immune cells

Treatment of cancer using chimeric antigen receptor and protein kin...

TCR/BCR profiling using enrichment with pools of capture probes

Anti-GPC3 antibody

Methods, kits, agents and apparatuses for transduction

Blockade of CD2 surface expression and expression of chimeric antig...

Chimeric antigen receptors and uses thereof

BCMA chimeric antigen receptor based on single domain antibody and...

Peptides and combination of peptides for use in immunotherapy again...

Method of redirecting t cells to treat HIV infection

Compositions and methods for treating cancer with anti-CD19/CD22 im...

Gene-regulating compositions and methods for improved immunotherapy

Human alpha-folate receptor chimeric antigen receptor

Chimeric antigen receptor for tumor targeting

Patents Applicationslast 30 patents

METHODS FOR THE TREATMENT OF ANAPLASTIC LARGE CELL LYMPHOMA

COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION

NUCLEIC ACID CONSTRUCT

METHOD FOR ENHANCING THE SUPPRESSIVE PROPERTIES OF TREG CELLS

ANTI-GPRC5D ANTIGEN BINDING PROTEIN AND USE THEREOF

GENETICALLY ENGINEERED CELLS AND USES THEREOF

METHODS OF TREATMENT

ANTIBODY LOADED IMMUNE CELLS AND METHODS FOR USE IN CANCER TREATMENT

CD4+ AND/OR CD8+ CELL POPULATIONS COMPRISING ICARS FOR USE IN TREAT...

COMPOSITIONS AND METHODS OF PHOSPHOLIPASE A2 RECEPTOR CHIMERIC AUTO...

BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

CELLULAR THERAPY TO SUPPRESS IMMUNE RESPONSE

METHODS AND COMPOSITION USING PATIENT-DERIVED AUTOLOGOUS NEOANTIGEN...

CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS ME...

COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO...

COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS

TFR ANTIGEN BINDING PROTEINS AND USES THEREOF

BAG6 SPECIFIC CHIMERIC ANTIGEN RECEPTOR, NUCLEIC ACID, BAG6 SPECIFI...

BINDING DOMAIN

COMBINATION OF ANTIGEN SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-ST...

NR4A3-DEFICIENT IMMUNE CELLS AND USES THEREOF

GENERATION OF CAR MODIFIERS FOR TUMOR TREATMENT

T Cell Modification

Cell Selection Methods and Related Compositions

CAR-EXPRESSING IMMUNE CELLS THAT SPECIFICALLY TARGET MESOTHELIN AND...

VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS

Chimeric Antigen Receptor-Modified NK-92 Cells

MULTISPECIFIC ANTIGEN-BINDING MOLECULES FOR CELL TARGETING AND USES...

CAR T CELL THERAPY AND IFN GAMMA

FUSION PROTEINS AND USES THEREOF